Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: Results of a phase II North Central Cancer Treatment Group trial

Thomas E. Witzig, Louis Letendre, James Gerstner, Georgene Schroeder, James A. Mailliard, Gerardo Colon-Otero, Robert F. Marschke, Harold E. Windschitl

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: Results of a phase II North Central Cancer Treatment Group trial'. Together they form a unique fingerprint.

Medicine & Life Sciences